Ozempic is not FDA-approved for weight loss, which makes getting a prescription specifically for that purpose more complicated than you might expect. The same active ingredient, semaglutide, is approved for weight management under a different brand name: Wegovy. Understanding that distinction is the first step, because it shapes everything from how your doctor writes the prescription to whether your insurance will cover it.
Why Ozempic Isn’t a Weight Loss Drug (Officially)
The FDA approved Ozempic for two purposes: improving blood sugar control in adults with type 2 diabetes and reducing cardiovascular risk in adults with type 2 diabetes and heart disease. That’s it. There is no FDA-approved weight loss indication for Ozempic.
Wegovy, on the other hand, contains the same compound at a slightly higher maximum dose. Wegovy goes up to 2.4 mg per week, while Ozempic tops out at 2 mg. The clinical results behind these medications are striking: in the landmark STEP 1 trial, people taking semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. More than 86% of participants lost at least 5% of their starting weight.
Doctors can legally prescribe Ozempic off-label for weight loss. Off-label prescribing is common across medicine, and it’s not illegal or unethical. But it does create friction with insurance companies, which typically won’t cover a drug for a use the FDA hasn’t approved.
Who Qualifies for a Prescription
Whether your doctor prescribes Ozempic off-label or steers you toward Wegovy, the eligibility criteria for weight management are generally the same. You typically need a BMI of 30 or greater. If your BMI is 27 or above, you may still qualify if you have a weight-related health condition such as high blood pressure, sleep apnea, or type 2 diabetes.
If you do have type 2 diabetes, the path is more straightforward. Ozempic is on-label for that condition, and any weight loss becomes a welcome secondary benefit. Many doctors prescribe Ozempic to patients with type 2 diabetes knowing full well that weight management is part of the treatment picture.
Your doctor will also screen for contraindications. You should not take semaglutide if you have a personal or family history of a specific type of thyroid cancer called medullary thyroid carcinoma, or a condition called Multiple Endocrine Neoplasia syndrome type 2. A history of pancreatitis is another red flag that may steer your provider toward a different medication.
What Happens at Your Appointment
The evaluation is relatively simple. Your provider will take your weight and blood pressure, ask about your medical and family histories, and likely order bloodwork. The most common tests are a fasting blood glucose level and a hemoglobin A1c, which measures blood sugar control over the previous three months. These help determine whether type 2 diabetes or prediabetes is part of your clinical picture, which directly affects how the prescription is written and coded for insurance.
Be prepared to discuss what you’ve already tried. Many insurers and providers want to see that you’ve made genuine attempts at lifestyle changes, including diet and exercise modifications, before turning to medication. Some insurance plans have formal “step therapy” requirements, meaning you may need to have tried and failed other treatments first. Documenting your weight management history, even informally, strengthens your case.
You don’t necessarily need to see a specialist. Primary care doctors, endocrinologists, and obesity medicine physicians all prescribe these medications. Telehealth platforms have also become a common route. The consultation process through telehealth generally mirrors an in-person visit: you’ll answer medical history questions, share your weight and vitals, and sometimes complete lab work at a local facility before the provider finalizes a prescription.
The Insurance Problem
This is where most people hit a wall. If you don’t have type 2 diabetes, getting insurance to cover Ozempic for weight loss is extremely difficult. Ozempic requires prior authorization from most insurers even for its approved use. A policy from Aetna, for example, requires a diagnosis of type 2 diabetes, evidence that you’ve tried and failed metformin (or have a contraindication to it), or that you need combination therapy with an A1c of 7.5% or higher.
For weight loss specifically, Wegovy is the more insurance-friendly option because it actually carries the FDA approval. But even Wegovy coverage is inconsistent. Many commercial plans cover it, but others exclude weight management drugs entirely. Medicare coverage for weight loss medications has been limited historically, though the policy landscape continues to shift.
Without insurance, semaglutide injectables cost over $1,300 per month at retail. Novo Nordisk offers a savings card for people without insurance, but federal law prohibits copayment coupons for anyone enrolled in government health care programs like Medicare or Medicaid.
Ozempic vs. Wegovy: Which to Ask About
If weight loss is your primary goal and you don’t have type 2 diabetes, asking your doctor about Wegovy rather than Ozempic will generally make the process smoother. The FDA indication aligns with your reason for taking it, insurance is more likely to cooperate, and the maximum dose is slightly higher.
If you have type 2 diabetes or prediabetes, Ozempic may be the better fit. Your doctor can prescribe it on-label for blood sugar management, you’ll get the weight loss benefits alongside glycemic control, and insurance approval becomes far more achievable. Some doctors may also prescribe Ozempic off-label for weight loss when Wegovy is unavailable due to supply shortages, documenting the medical necessity carefully.
Both medications are once-weekly injections using a prefilled pen. Both start at a low dose and gradually increase over several weeks to minimize side effects. The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, bloating, and heartburn. These tend to be worst during dose increases and improve over time for most people.
Avoid Compounded and Counterfeit Versions
The high cost and limited availability of brand-name semaglutide have pushed some people toward compounded versions sold through online pharmacies or wellness clinics. The FDA has issued warnings about this. Compounded semaglutide is not reviewed by the FDA for safety, effectiveness, or quality. The dosing may be inaccurate, the formulation may contain different salt forms of the drug, and there’s no guarantee of sterility or potency.
The FDA has also flagged counterfeit Ozempic pens circulating in the U.S. These products claim to be authentic but may contain the wrong ingredients, incorrect doses, or no active ingredient at all. If you’re getting semaglutide, fill the prescription at a licensed pharmacy using a product that comes in original manufacturer packaging.
What to Expect After Starting
Semaglutide is not an overnight solution. The dose escalation alone takes several weeks, and meaningful weight loss typically becomes visible over months. In clinical trials, the 14.9% average weight loss was measured at 68 weeks, roughly 16 months. Your results will depend on your starting weight, how well you tolerate the medication, and whether you’re also making changes to diet and physical activity.
Plan on regular follow-ups. Your provider will monitor your weight, check in on side effects, and adjust your dose as needed. If you have diabetes, A1c and blood sugar monitoring will continue. Most people stay on the medication long-term, as weight tends to return after stopping. That makes the cost and insurance question not just an upfront concern but an ongoing one worth sorting out early.